UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report)'s stock price was up 1.8% during trading on Friday after Deutsche Bank Aktiengesellschaft raised their price target on the stock from $545.00 to $562.00. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock. UnitedHealth Group traded as high as $504.75 and last traded at $502.10. Approximately 1,872,487 shares were traded during trading, a decline of 58% from the average daily volume of 4,485,528 shares. The stock had previously closed at $493.18.
A number of other equities analysts have also commented on UNH. Morgan Stanley lowered their price target on shares of UnitedHealth Group from $618.00 to $584.00 and set an "overweight" rating on the stock in a research report on Friday, April 5th. Piper Sandler raised their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an "overweight" rating in a report on Wednesday. Truist Financial reissued a "buy" rating and issued a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday. Bank of America reissued a "buy" rating and issued a $675.00 target price on shares of UnitedHealth Group in a report on Thursday, March 7th. Finally, Cantor Fitzgerald reissued an "overweight" rating and issued a $591.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 10th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $570.05.
View Our Latest Stock Analysis on UnitedHealth Group
Insider Buying and Selling
In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm's stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm's stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the firm's stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company's stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.
Institutional Trading of UnitedHealth Group
Several hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. increased its stake in shares of UnitedHealth Group by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 83,860,515 shares of the healthcare conglomerate's stock valued at $44,150,045,000 after acquiring an additional 250,291 shares in the last quarter. Wellington Management Group LLP increased its stake in shares of UnitedHealth Group by 2.1% in the 3rd quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate's stock valued at $12,715,790,000 after acquiring an additional 527,526 shares in the last quarter. Morgan Stanley increased its stake in UnitedHealth Group by 13.8% during the 4th quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate's stock valued at $8,289,386,000 after purchasing an additional 1,893,192 shares in the last quarter. Capital Research Global Investors increased its stake in UnitedHealth Group by 2.2% during the 4th quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate's stock valued at $7,961,369,000 after purchasing an additional 324,733 shares in the last quarter. Finally, Capital International Investors increased its stake in UnitedHealth Group by 4.8% during the 4th quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate's stock valued at $6,244,158,000 after purchasing an additional 542,424 shares in the last quarter. Institutional investors own 87.86% of the company's stock.
UnitedHealth Group Stock Up 1.6 %
The firm has a market cap of $462.16 billion, a P/E ratio of 30.64, a price-to-earnings-growth ratio of 1.31 and a beta of 0.54. The stock's 50 day simple moving average is $488.63 and its 200 day simple moving average is $515.13. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts' consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group's quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $6.26 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.74 EPS for the current year.
UnitedHealth Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.50%. The ex-dividend date was Friday, March 8th. UnitedHealth Group's dividend payout ratio is 45.97%.
About UnitedHealth Group
(
Get Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
